【结 构 式】 ![]() |
【药物名称】CP-93318 【化学名称】4-(2-Methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole 【CA登记号】129486-32-4, 130096-16-1 (tritiated analog) 【 分 子 式 】C15H15N3OS 【 分 子 量 】285.3703 |
【开发单位】Pfizer Central Research (Originator) 【药理作用】Nausea and Vomiting, Treatment of, NEUROLOGIC DRUGS, 5-HT3 Antagonists |
合成路线1
The synthesis of CP-93,318 is summarized: Treatment of 4-methyl-5-imidazolemethanol (I) with thionyl chloride affords chloromethylimidazole (II). Exposure of (II) to potassium cyanide provides nitrile (III), and subsequent reaction of (III) with diethyldithiophosphate in the presence of hydrochloric acid gives thioamide (IV), as its hydrochloride salt. Condensation of this hygroscopic salt with 2-bromo-2'-methoxyacetophenone (V) provides thiazole CP-93,318. Analogues of CP-93,318, modified at the methoxyphenyl moiety, were prepared similarly by condensation of convergent intermediate (IV) and the appropriate alpha-haloketone.
【1】 Rizzi, J.P.; Guarino, K.; Vincent, L.A.; Ganong, A.H.; Siok, C.J.; Ives, J.L.; Nowakowski, J.T.; Seeger, T.F.; Rosen, T.; Heym, J.; Nagel, A.A.; Daffeh, J.B.; McLean, S.; Schmidt, A.W.; Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists. J Med Chem 1990, 33, 2715-20. |
【2】 Rosen, T.; Nagel, A.A.; CP-93,318. Drugs Fut 1991, 16, 11, 992. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14216 | (5-Methyl-1H-imidazol-4-yl)methanol | 29636-87-1 | C5H8N2O | 详情 | 详情 |
(II) | 14217 | 4-(Chloromethyl)-5-methyl-1H-imidazole | C5H7ClN2 | 详情 | 详情 | |
(III) | 14218 | 2-(5-Methyl-1H-imidazol-4-yl)acetonitrile | C6H7N3 | 详情 | 详情 | |
(IV) | 14219 | 2-(5-Methyl-1H-imidazol-4-yl)ethanethioamide hydrochloride | C6H9N3S | 详情 | 详情 | |
(V) | 14220 | 2-Bromo-1-(2-methoxyphenyl)-1-ethanone | 31949-21-0 | C9H9BrO2 | 详情 | 详情 |
合成路线2
The synthesis of a tritiated analogue of CP-93,318 is as follows: Treatment of the phenacyl bromide (V) with N-bromosuccinimide in methanol affords selectively bromo derivative (VI). Subsequent condensation of (VI) and thioamide (IV) (Scheme 1) provides tritiation precursor (VII). Exposure of (VII) to tritium in the presence of palladium on carbon (triethylamine/tetrahydrofuran) followed by purification using high-performance liquid chromatography provides [3H]-CP-93,318 (specific activity: 16.2 Ci/mmol, radiochemical purity greater than or equal to 98%).
【1】 Guarino, K.J.; Furman, J.; Rosen, T.; Chalabi, P.M.; Ives, J.L.; Windels, J.H.; McLean, S.; Nagel, A.A.; Bryce, D.; Seeger, T.F.; Roth, R.W.; Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. J Med Chem 1990, 33, 11, 3020-3. |
【2】 Rosen, T.; Nagel, A.A.; CP-93,318. Drugs Fut 1991, 16, 11, 992. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IV) | 14219 | 2-(5-Methyl-1H-imidazol-4-yl)ethanethioamide hydrochloride | C6H9N3S | 详情 | 详情 | |
(V) | 14220 | 2-Bromo-1-(2-methoxyphenyl)-1-ethanone | 31949-21-0 | C9H9BrO2 | 详情 | 详情 |
(VI) | 14221 | 2-Bromo-1-(5-bromo-2-methoxyphenyl)-1-ethanone | C9H8Br2O2 | 详情 | 详情 | |
(VII) | 14222 | 4-Bromo-2-[2-[(5-methyl-1H-imidazol-4-yl)methyl]-1,3-thiazol-4-yl]phenyl methyl ether; 4-(5-Bromo-2-methoxyphenyl)-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1,3-thiazole | C15H14BrN3OS | 详情 | 详情 |